Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

DeNovX Licenses Pharmaceutical Manufacturing Patent Estate

Posted 6/5/2013

Chicago, June 5, 2013 - Illinois Institute of Technology (IIT) and DeNovX, LLC, an Illinois-based life sciences company, are pleased to announce that DeNovX has licensed from IIT five issued patents providing improved processing methods for pharmaceutical R&D and production.  The technologies involve breakthrough methods of forming crystalline materials of relevance to pharmaceutical manufacturing and were developed from research performed in the Department of

Chemical Engineering at IIT over a six year period, with financial support from both public and commercial sources.  

 

"IIT has high confidence in the ability of DeNovX to successfully bring these technologies to the pharmaceutical markets,” said IIT Director of Technology Transfer and Intellectual Property Robert Anderson. “DeNovX’s management team has the skill and experience to navigate the challenging journey towards commercialization."  

 

"These patented crystallization technologies are a foundation from which DeNovX will build profitable products and services that improve productivity in pharmaceutical R&D and manufacturing activities,” DeNovX Chief Executive Officer Kevin Schaab said.  

 

“Our proximity to the burgeoning biosciences community in the Midwest, which includes IIT, creates attractive opportunities for DeNovX to grow this business,” adds DeNovX Chief Business Officer Andrew Bond.  “The technologies licensed from IIT are simultaneously elegant and pragmatic, and we will repurpose established manufacturing methods to accelerate product development in anticipation of rapid adoption by innovator and generic pharmaceutical companies and the Contract Research Organizations that serve them.”  

 

For more information, contact Andrew Bond, Ph.D. at DeNovX: info (at) DeNovX.com or 910-333-6689.

 

About Illinois Institute of Technology (IIT)

Founded in 1890, IIT is a Ph.D.-granting university offering degrees in engineering, sciences, architecture, psychology, design, humanities, business, and law.  IIT's interprofessional, technology-focused curriculum is designed to advance knowledge through research and scholarship, to cultivate invention improving the human condition, and to prepare students from throughout the world for a life of professional achievement, service to society, and individual fulfillment. Visit www.iit.edu.

 

About DeNovX, LLC

DeNovX is a life sciences company with patented products that accelerate pharmaceutical development, make drug manufacturing more predictable, and are scalable across the spectrum from discovery to production.  With industry relevant expertise, patented product offerings, and locations in Chicago and San Diego, DeNovX is strategically positioned to serve those high value pharmaceutical industry customers for which crystal form control is both a regulatory requirement and a competitive imperative.  Visit www.DeNovX.com.